Prévalence mondiale du virus de l'hépatite C chez les femmes en âge de procréer en 2019 : une étude de modélisation
Summary Background Treatment for infection with hepatitis C virus (HCV) during pregnancy has not yet been approved; however, interventions specifically targeting women, especially those of childbearing age (15–49 years), could prevent vertical transmission and community spread. To assess the impact of such interventions, improved prevalence estimates in this group are needed. We aimed to estimate […]
French 
English 
Spanish 
Russian 
Arabic